Evaluation of the Tolerance & Safety of a New Partly Fermented

See also
Status	Clinical Trial	Phase
Completed	`NCT01956682` - Hypoallergenic Infant Formula Containing Starch and the Probiotic: Effect on Gastric Emptying	Phase 4
Active, not recruiting	`NCT05363553` - Transition to Infant Formula Feeding on Gastrointestinal Regurgitation (TIGER) Study	N/A
Completed	`NCT04042454` - To Assess the Safety and Tolerance of Infant Formula With Locust Bean Gum in Infants With Regurgitation	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT01956682 - Hypoallergenic Infant Formula Containing Starch and the Probiotic: Effect on Gastric Emptying

Phase 4

Active, not recruiting

NCT05363553 - Transition to Infant Formula Feeding on Gastrointestinal Regurgitation (TIGER) Study

N/A

Completed

NCT04042454 - To Assess the Safety and Tolerance of Infant Formula With Locust Bean Gum in Infants With Regurgitation

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT03371615
Study type	Interventional
Source	Nutricia Research
Contact
Status	Completed
Phase	N/A
Start date	November 4, 2017
Completion date	September 6, 2019

Evaluation of the Tolerance and Safety of a New Partly Fermented Anti-regurgitation Infant Formula — Leopard

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms